Non-Current Liabilities
Contract Liabilities, Non-Current
Moderna Contract Liabilities, Non-Current increased by 0.7% to $154.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 165.5%, from $58.00M to $154.00M. Over 5 years (FY 2020 to FY 2025), Contract Liabilities, Non-Current shows a downward trend with a -2.9% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Liabilities
First reportedQ4 2018
Last reportedQ1 2026May 1, 2026
Metric ID:
contract_liabilities_noncurrentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $175.00M | $498.00M | $615.00M | $464.00M | $405.00M | $175.00M | $673.00M | $673.00M | $692.00M | $166.00M | $83.00M | $58.00M | $95.00M | $95.00M | $58.00M | $58.00M | $65.00M | $157.00M | $153.00M | $154.00M |
| QoQ Change | — | +184.6% | +23.5% | -24.6% | -12.7% | -56.8% | +284.6% | +0.0% | +2.8% | -76.0% | -50.0% | -30.1% | +63.8% | +0.0% | -38.9% | +0.0% | +12.1% | +141.5% | -2.5% | +0.7% |
| YoY Change | — | — | — | — | +131.4% | -64.9% | +9.4% | +45.0% | +70.9% | -5.1% | -87.7% | -91.4% | -86.3% | -42.8% | -30.1% | +0.0% | -31.6% | +65.3% | +163.8% | +165.5% |
Range$58.00M – $692.00M
CAGR-2.7%
Avg YoY Growth+13.2%
Median YoY Growth-2.6%
Contract Liabilities, Non-Current at Other Companies
Frequently Asked Questions
- What is Moderna's contract liabilities, non-current?
- Moderna (MRNA) reported contract liabilities, non-current of $154.00M in Q1 2026.
- How has Moderna's contract liabilities, non-current changed year-over-year?
- Moderna's contract liabilities, non-current increased by 165.5% year-over-year, from $58.00M to $154.00M.
- What is the long-term trend for Moderna's contract liabilities, non-current?
- Over 5 years (2020 to 2025), Moderna's contract liabilities, non-current has grown at a -2.9% compound annual growth rate (CAGR), from $177.00M to $153.00M.